VC firms
At LYFE, we share the passion of our entrepreneurs in their objectives of striving for a better world; one step at a time. Not only do we invest in healthcare but we also bring significant deep seated China knowledge and international business experience to accelerate our partners in their growth, expanding a strong stable company more readily to take on the challenges in the China market.
Overview
Location
China, Shanghai
Employees
11-50
Founded date
2015
Investment Type
Venture Capital
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2025 | PE firms see value in expanding Korean medical aesthetics abroad: LYFE Capital | |
| Feb 9, 2024 | Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics | 09/02/2024 Nota de prensa YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond... |
Reviews 0
FAQ about LYFE Capital
When was LYFE Capital founded?
LYFE Capital was founded in 2015.
What has the press written about LYFE Capital?
Parsers VC has collected 3 articles mentioning LYFE Capital, among them “PE firms see value in expanding Korean medical aesthetics abroad: LYFE Capital” (Oct 13, 2025) and “Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics” (Feb 9, 2024).
Is LYFE Capital still active?
Yes, LYFE Capital is active; its latest activity on Parsers VC dates from Oct 25, 2026.